Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingdi Zhang

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
International Journal of General Medicine|August 26, 2021
<i>HOTAIR</i> Facilitates Endocrine Resistance in Breast Cancer Through <i>ESR1</i>/<i>miR-130b-3p</i> Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA NetworkMingdi Zhang, Kejin Wu, Peng Zhang, et al.
Breast Cancer Research and Treatment|April 26, 2019
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysisMaoli Wang, Hongliang Chen, Kejin Wu, et al.
Applied Optics|November 19, 2016
Metal-enhanced fluorescence of single shell-isolated alloy metal nanoparticleChengyun Zhang, Qingyan Han, Caixia Li, et al.
Cancer Medicine|October 27, 2017
Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysisHongliang Chen, Kejin Wu, Maoli Wang, et al.
Breast (Edinburgh, Scotland)|March 8, 2018
Reply to Woodward et al.: A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancerHongliang Chen, Kejin Wu, Maoli Wang, et al.
Frontiers in Immunology|May 8, 2026
YKT6 promotes breast cancer progression and is associated with poor prognosis and immune infiltrationMeilin Zhang, Jingjing Yuan, Yaxuan Liu, et al.
Annals of Surgical Oncology|November 21, 2018
The Prognostic Significance of the Oncotype DX Recurrence Score in T<sub>1-2</sub>N<sub>1</sub>M<sub>0</sub> Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th EditionMaoli Wang, Kejin Wu, Peng Zhang, et al.
Cancer Biology & Therapy|December 18, 2025
Validation of the important role and prognostic value of KIF14 in triple-negative breast cancerJingjing Yuan, Meilin Zhang, Yaxuan Liu, et al.
The Journal of Surgical Research|March 12, 2019
Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast CancerHongliang Chen, Peng Zhang, Mingdi Zhang, et al.
Breast (Edinburgh, Scotland)|June 27, 2017
A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18Hongliang Chen, Kejin Wu, Maoli Wang, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
International Journal of General Medicine|August 26, 2021
<i>HOTAIR</i> Facilitates Endocrine Resistance in Breast Cancer Through <i>ESR1</i>/<i>miR-130b-3p</i> Axis: Comprehensive Analysis of mRNA-miRNA-lncRNA NetworkMingdi Zhang, Kejin Wu, Peng Zhang, et al.
Breast Cancer Research and Treatment|April 26, 2019
Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysisMaoli Wang, Hongliang Chen, Kejin Wu, et al.
Applied Optics|November 19, 2016
Metal-enhanced fluorescence of single shell-isolated alloy metal nanoparticleChengyun Zhang, Qingyan Han, Caixia Li, et al.
Cancer Medicine|October 27, 2017
Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysisHongliang Chen, Kejin Wu, Maoli Wang, et al.
Breast (Edinburgh, Scotland)|March 8, 2018
Reply to Woodward et al.: A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancerHongliang Chen, Kejin Wu, Maoli Wang, et al.
Frontiers in Immunology|May 8, 2026
YKT6 promotes breast cancer progression and is associated with poor prognosis and immune infiltrationMeilin Zhang, Jingjing Yuan, Yaxuan Liu, et al.
Annals of Surgical Oncology|November 21, 2018
The Prognostic Significance of the Oncotype DX Recurrence Score in T<sub>1-2</sub>N<sub>1</sub>M<sub>0</sub> Estrogen Receptor-Positive HER2-Negative Breast Cancer Based on the Prognostic Stage in the Updated AJCC 8th EditionMaoli Wang, Kejin Wu, Peng Zhang, et al.
Cancer Biology & Therapy|December 18, 2025
Validation of the important role and prognostic value of KIF14 in triple-negative breast cancerJingjing Yuan, Meilin Zhang, Yaxuan Liu, et al.
The Journal of Surgical Research|March 12, 2019
Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast CancerHongliang Chen, Peng Zhang, Mingdi Zhang, et al.
Breast (Edinburgh, Scotland)|June 27, 2017
A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18Hongliang Chen, Kejin Wu, Maoli Wang, et al.
Pageof 10